Showing results (1311-1320 of 2,286) with videos related to
Sort By:
Pageof 229
HIV Medicine|May 7, 2005
Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patientsE Seminari, A Castagna, A Soldarini, et al.HIV Medicine|May 7, 2005
Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patientsS Abdulle, L Hagberg, M GisslénHIV Medicine|May 7, 2005
The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxisA Winston, J McAllister, J Amin, et al.HIV Medicine|May 7, 2005
Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD)J Zhou, N Kumarasamy, HIV Medicine|November 17, 2004
Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimensE R Lanier, N Givens, C Stone, et al.HIV Medicine|November 17, 2004
An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapyV Ormaasen, L Sandvik, B Asjø, et al.HIV Medicine|February 24, 2006
Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophyG J Moyle, S Brown, L Lysakova, et al.HIV Medicine|February 24, 2006
Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002K C W Chan, K H Wong, S S LeeHIV Medicine|February 24, 2006
Low initial trough plasma concentrations of lopinavir are associated with an impairment of virological response in an unselected cohort of HIV-1-infected patientsM I Wateba, E Billaud, E Dailly, et al.HIV Medicine|January 26, 2008
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006A Nguyen, A Calmy, V Schiffer, et al.Pageof 229